{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:09:00Z","timestamp":1792030140867,"version":"4.4.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/aog.0b013e3181fc3afa","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:21:31Z","timestamp":1292977291000},"page":"75-83","source":"Crossref","is-referenced-by-count":128,"title":["Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes"],"prefix":"10.1097","volume":"117","author":[{"given":"Anne M.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Giclas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210126","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts.","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-12-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: a delicate balance.","volume":"30","author":"Sj\u00f6berg","year":"2009","journal-title":"Trends Immunol"},{"key":"R3-12-20210126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2008.00641.x","article-title":"The spectrum of complement alternative pathway-mediated diseases.","volume":"223","author":"Holers","year":"2008","journal-title":"Immunol Rev"},{"key":"R4-12-20210126","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight.","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J Pathol"},{"key":"R5-12-20210126","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R6-12-20210126","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis.","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"R7-12-20210126","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0950-3552(05)80005-7","article-title":"Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship.","volume":"6","author":"Holmes","year":"1992","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"R8-12-20210126","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.placenta.2010.03.010","article-title":"Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.","volume":"31","author":"Lynch","year":"2010","journal-title":"Placenta"},{"key":"R9-12-20210126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1074-7613(03)00028-1","article-title":"At the innate frontiers between mother and fetus: linking abortion with complement activation.","volume":"18","author":"Caucheteux","year":"2003","journal-title":"Immunity"},{"key":"R10-12-20210126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"issue":"suppl 2","key":"R11-12-20210126","doi-asserted-by":"crossref","first-page":"ii46","DOI":"10.1136\/ard.61.suppl_2.ii46","article-title":"Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.","volume":"61","author":"Salmon","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R12-12-20210126","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia.","volume":"198","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R13-12-20210126","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajog.2008.07.044","article-title":"Complement activation fragment Bb in early pregnancy and spontaneous preterm birth.","volume":"199","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R14-12-20210126","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R15-12-20210126","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"R16-12-20210126","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2008.07324.x","article-title":"Advances in understanding of pathogenesis of aHUS and HELLP.","volume":"143","author":"Fang","year":"2008","journal-title":"Br J Haematol"},{"key":"R17-12-20210126","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1471-0528.2009.02473.x","article-title":"The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.","volume":"117","author":"Lynch","year":"2010","journal-title":"BJOG"},{"key":"R18-12-20210126","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia.","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"R19-12-20210126","first-page":"294","article-title":"Embryonic death in early pregnancy: a new look at the first trimester.","volume":"84","author":"Goldstein","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R20-12-20210126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0029-7844(95)00498-X","article-title":"Antiphospholipid antibodies and fetal death.","volume":"87","author":"Oshiro","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R21-12-20210126","first-page":"635","article-title":"Creasy and Resnick's maternal\u2013fetal medicine: principles and practice.","author":"Resnick","year":"2009"},{"key":"R22-12-20210126","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.32.5.793","article-title":"Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation.","volume":"32","author":"Lubchenco","year":"1963","journal-title":"Pediatrics"},{"key":"R23-12-20210126","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clp.2004.06.004","article-title":"Preterm premature rupture of the membranes: diagnosis and management.","volume":"31","author":"Mercer","year":"2004","journal-title":"Clin Perinatol"},{"key":"R24-12-20210126","first-page":"545","article-title":"Creasy and Resnick's maternal\u2013fetal medicine: principles and practice. 6th ed.","author":"Iams","year":"2009"},{"key":"R25-12-20210126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jri.2007.03.015","article-title":"Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update.","volume":"76","author":"Dekker","year":"2007","journal-title":"J Reprod Immunol"},{"key":"R26-12-20210126","doi-asserted-by":"crossref","first-page":"c3920","DOI":"10.1136\/bmj.c3920","article-title":"Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review.","volume":"341","author":"Cordoba","year":"2010","journal-title":"BMJ"},{"key":"R27-12-20210126","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia.","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol"},{"key":"R28-12-20210126","first-page":"551","article-title":"Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.","volume":"73","author":"Haeger","year":"1989","journal-title":"Obstet Gynecol"},{"key":"R29-12-20210126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.siny.2006.05.001","article-title":"Inflammation in preterm and term labour and delivery.","volume":"11","author":"Romero","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"R30-12-20210126","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1515\/JPM.2005.051","article-title":"Anaphylatoxins in preterm and term labor.","volume":"33","author":"Soto","year":"2005","journal-title":"J Perinat Med"},{"key":"R31-12-20210126","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/14767050902994747","article-title":"Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.","volume":"22","author":"Soto","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R32-12-20210126","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0897.2009.00800.x","article-title":"Activation of the alternative pathway of complement is a feature of pre-term parturition but not of spontaneous labor at term.","volume":"63","author":"Vaisbuch","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"R33-12-20210126","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molimm.2008.07.025","article-title":"Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates.","volume":"46","author":"Swierzko","year":"2009","journal-title":"Mol Immunol"},{"key":"R34-12-20210126","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0029-7844(98)00123-9","article-title":"Amniotic fluid complement C3 as a marker of intra-amniotic infection.","volume":"92","author":"Elimian","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R35-12-20210126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00006250-199203000-00005","article-title":"The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor.","volume":"79","author":"Watts","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R36-12-20210126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2006-956773","article-title":"The role of inflammation and infection in preterm birth.","volume":"25","author":"Romero","year":"2007","journal-title":"Semin Reprod Med"},{"key":"R37-12-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy.","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"R38-12-20210126","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00006250-200305000-00005","article-title":"Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.","volume":"101","author":"Andrews","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R39-12-20210126","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0167-5699(93)90235-D","article-title":"Bidirectional cytokine interactions in the maternal\u2013fetal relationship: is successful pregnancy a TH2 phenomenon?","volume":"14","author":"Wegmann","year":"1993","journal-title":"Immunol Today"},{"key":"R40-12-20210126","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00281-007-0069-0","article-title":"The Th1\/Th2 paradigm: still important in pregnancy?","volume":"29","author":"Chaouat","year":"2007","journal-title":"Semin Immunopathol"},{"issue":"suppl A","key":"R41-12-20210126","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.placenta.2007.10.011","article-title":"Cytokine signaling, inflammation, innate immunity and preterm labour\u2014a workshop report.","volume":"29","author":"Blank","year":"2008","journal-title":"Placenta"},{"key":"R42-12-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/JPM.1999.001","article-title":"Markers of risk for preterm delivery.","volume":"27","author":"Lockwood","year":"1999","journal-title":"J Perinat Med"},{"key":"R43-12-20210126","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.fertnstert.2007.05.046","article-title":"Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage.","volume":"89","author":"Whitcomb","year":"2008","journal-title":"Fertil Steril"},{"issue":"suppl A","key":"R44-12-20210126","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1053\/plac.2002.0930","article-title":"Pre-eclampsia, the placenta and the maternal systemic inflammatory response\u2014a review.","volume":"24","author":"Redman","year":"2003","journal-title":"Placenta"},{"key":"R46-12-20210126","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts.","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0b013e3181fc3afa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:35:39Z","timestamp":1785857739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201101000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181fc3afa","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.8785957.9312055","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}